CASI Pharmaceuticals, Inc. (CASIF) stock
CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
CASI Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was -217.3%, against -138.8% the year before. The highest annual figure on record is -74.0% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -217.3% | −78.5 |
| FY2024 | Dec 31, 2024 | -138.8% | −64.8 |
| FY2023 | Dec 31, 2023 | -74.0% | +4.9 |
| FY2022 | Dec 31, 2022 | -78.9% | +58.7 |
| FY2021 | Dec 31, 2021 | -137.6% | +211.0 |
| FY2020 | Dec 31, 2020 | -348.6% | – |
See a number that looks wrong?